High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

201730 citationsJournal Articlegreen Open Access

Authors

Vedolizumab provides an effective and well-tolerated treatment option in real-world clinical practice even among treatment refractory IBD patients.

Good health and well-being

Published in: Scandinavian Journal of Gastroenterology

Volume 53, Issue 2, pp. 158-167

Field-Weighted Citation Impact: 4.20